Navigation Links
Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro
Date:7/26/2010

tial to form the foundation for a better treatment regimen for TB and MDR-TB patients everywhere. We look forward to the further substantiation of these results during the in vivo phase of our partnership with Tibotec. "

SQ-109 is a new diamine antibiotic intended to replace one or more of the current first-line anti-TB drugs to improve and simplify patient therapy. SQ109 was granted U.S. FDA Fast Track designation and FDA/EMEA Orphan Drug Designation in 2007. SQ109 shows activity against drug sensitive and multi-drug resistant (MDR and XDR) Mycobacterium tuberculosis, the causative agent of TB. SQ109 has successfully completed its Phase I safety studies and will begin its Phase II clinical efficacy program 2H 2010 in a number of sites in Africa.

About Sequella

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for life-threatening infectious diseases. The company leverages its global influence, R&D platforms, and disease expertise to proactively address emerging health threats. Through focused execution, clear commercialization pathways, and strategic partnerships, Sequella intends to commercialize a broad product portfolio designed to treat global health threats with significant market opportunity.

Forward-Looking Statement

This press release contains forward-looking statements that are subject to risks and uncertainties, and includes statements that are not historical facts. Actual results could differ significantly from results discussed. Sequella disclaims any intent or obligation to update forward-looking statements, except as required by law.

For more information contact: Alan S. Klein (

SOURCE Sequella, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
2. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
3. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
4. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
5. CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas
6. New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations
7. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015   Mast Therapeutics, Inc. ... its molecular adhesion and sealant technology (MAST) platform ... heart failure, and arterial disease, today announced that ... Board of Directors. Mr. Lief made this decision ... his role as President and Chief Executive Officer ...
(Date:5/28/2015)... DEKALB, Ill. , May 28, 2015 ... Intent to explore an affiliation with Northwestern Memorial ... and NMHC will further define the affiliation, which ... "KishHealth is recognized for their commitment to ... Dean M. Harrison , President and Chief Executive ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ... Aspects"  to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... individualized treatment is to match the right ... some cases, even to design the appropriate ...
Breaking Medicine Technology:Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... Reportlinker.com announces that a new ... Prostate Cancer - Italy Drug Forecasts and ... Prostate Cancer - Italy Drug Forecasts ... pharmaceutical report, "Prostate Cancer - Italy Drug Forecasts and ...
... 2010 Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery research, today announced ... to acquire privately-held Cambridge Research & Instrumentation, Inc. ...  CRi,s patented preclinical and tissue-based multiplexed analysis systems ...
Cached Medicine Technology:Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 2Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 3Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 4Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 5Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 6Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 7Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 8Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 9Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 10Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 11Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 12Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 13Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 14Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 2Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 3Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 4Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 5
(Date:5/28/2015)... Recently, KORT Richmond, 5006 Atwood Drive, added a new ... life. The program works with those new to prosthetic devices ... are still having difficulty. , According to the Amputee ... limb loss in the United States. The main causes of ... arterial disease – trauma (45%) and cancer (less than 2%), ...
(Date:5/28/2015)... The partners of Urgent Care of Westchester and ... Almendral as their chief provider for advanced beauty treatments. ... opened facility’s plan to offer all of Westchester County ... Almendral is a board certified physician who is trained ... techniques. Her areas of expertise include Botox, Dermal Fillers, ...
(Date:5/28/2015)... 2015 On Sunday, June 21, 2015, ... team event to honor the strength, passion and endurance ... solstice, the duration of this sunrise-to-sunset event symbolizes the ... their caregivers. Participants raise funds and awareness to advance ... Association. , Teams are encouraged to create their own ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 ... has announced an exclusive deal to patients looking to ... June 1 through 30, patients will be able to ... $800 procedure, for just $600. For a three-treatment package, ... fourth treatment at no cost. , Dr. Juanita Jenyons, ...
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO , today announced ... of president. , “ Bill Taaffe has a proven ... Flanagan, Medelis’ CEO and co-founder. “He will be a great ... growth.” , Taaffe joined ICON’s U.S. clinical operations in ... 4,500 employees, achieving 12 consecutive years of growth and regional ...
Breaking Medicine News(10 mins):Health News:KORT Richmond Physical Therapy Adds New Program to Help Amputees 2Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2
... ... on Friday, January 29 by Avalere Health, a Washington D.C.-based strategic and analytic consulting ... faced by the individual and small group markets in the purchase of health insurance. ... , ...
... , LOS ANGELES , Feb. 2 , ... touched even the youngest among us and we now see children taking ... early to start your kids on the right track to good health. ... on finding time to make delicious, affordable, and healthy meals for your ...
... day create exposure equal to inhaling nearly 3 more, study ... to the risks associated with directly inhaling cigarette smoke, smokers ... say. , The finding, published online Jan. 29 in ... threat posed to smokers by secondhand smoke is negligible. , ...
... ... The Accomplishing More With Less Workbook paperback and Kindle Edition at ... Manage Focused and Collaborative Time”, which is available for download at ... better manage the increasingly challenging work conditions and develop the skills ...
... , YONKERS, N.Y. ... area vary dramatically in terms of how well their intensive ... disability, and expense in our nations, hospitals that is largely preventable.  ... infection rates for 25 Boston area hospitals, along with ...
... ... hospital infection rates, a first for consumers , YONKERS, N.Y. ... expose patients to deadly central-line bloodstream infections despite the availability of a ... investigative article in the March issue of Consumer Reports . ...
Cached Medicine News:Health News:$7 Billion Potential Savings in Healthcare Reform 2Health News:$7 Billion Potential Savings in Healthcare Reform 3Health News:February Is Heart Month: These 4 Great Show Ideas Will Keep Your Audience Tuned In 2Health News:February Is Heart Month: These 4 Great Show Ideas Will Keep Your Audience Tuned In 3Health News:People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book 2Health News:People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book 3Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 2Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 3Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 4Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 5Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 6Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 7Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 2Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 3Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 4Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 5Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 6Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 7Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 8
Only Mobile Instrument offers complete repair and rebuild capability on all makes and models of endoscopy and laparoscopy instruments, using only factory-quality parts and precision techniques....
... Olympus fiber and video scopes including bronchoscopes, ... in OR and endoscopy. Quality is of ... exceed the standards of the OEM. We ... against defects in materials and workmanship. Quotes ...
Inquire...
... carefully inspects your camera upon arrival.,Our technician then ... provides you with a thorough customer quote. We ... tight budget so well help you prioritize repairs. ... repair begins., , ISI uses only OEM or ...
Medicine Products: